DOI QR코드

DOI QR Code

Evaluation of the iNtRON VRE vanA/vanB Real-Time PCR Assay for Detection of Vancomycin-Resistant Enterococci

  • Huh, Hee Jae (Department of Laboratory Medicine and Genetics, Sungkyunkwan University School of Medicine) ;
  • Jang, Mi-Ae (Department of Laboratory Medicine and Genetics, Sungkyunkwan University School of Medicine) ;
  • Seo, Ja Young (Department of Laboratory Medicine, Gachon University Gil Hospital) ;
  • Kim, Ji-Youn (Center for Clinical Medicine, Samsung Biomedical Research Institute, Samsung Medical Center) ;
  • Ki, Chang-Seok (Department of Laboratory Medicine and Genetics, Sungkyunkwan University School of Medicine) ;
  • Kim, Jong-Won (Department of Laboratory Medicine and Genetics, Sungkyunkwan University School of Medicine) ;
  • Lee, Nam Yong (Department of Laboratory Medicine and Genetics, Sungkyunkwan University School of Medicine)
  • Received : 2014.04.15
  • Accepted : 2014.10.13
  • Published : 2015.01.02

Abstract

Background: Recently, the iNtRON VRE vanA/vanB real-time PCR (iNtRON; iNtRON Biotechnology, Korea) assay, a multiplex real-time PCR method, was introduced. In this prospective study, we compared the iNtRON assay with the Seeplex VRE ACE detection kit (Seeplex; Seegene, Korea), a conventional multiplex PCR assay. Methods: A chromogenic agar-based culture, in which pre-selected vancomycin-resistant enterococci (VRE) was grown and subsequently plated on blood agar with vancomycin disks, was regarded as the reference method. A total of 304 consecutive rectal swab specimens were tested for VRE by culture and by iNtRON and Seeplex PCR assays. For the PCR assays, specimens were enriched for 16-24 hr before PCR. Results: VRE were isolated from 44 (14.5%) specimens by chromogenic agar-based culture. The clinical sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of the iNtRON assay were 100% (95% confidence interval: 89.8%-100%), 99.2% (96.9%-99.9%), 95.6% (83.6%-99.2%), and 100% (98.2%-100%), respectively, while those of the Seeplex assay were 97.7% (86.2%-99.9%), 99.6% (97.5%-99.9%), 97.7% (86.2%-99.9%), and 99.6% (97.5%-99.9%), respectively. The iNtRON assay had a detection limit of $3,159copies/{\mu}L $ and $13,702copies/{\mu}L$ for the vanA and vanB genes, respectively. No cross-reactivity was observed in 11 non-VRE bacterial culture isolates. Conclusions: The overall performance of the iNtRON assay was comparable to that of a chromogenic agar-based culture method for prompt identification of VRE-colonized patients in hospitals. This assay could be an alternative or supportive method for the effective control of nosocomial VRE infection.

Keywords

Acknowledgement

Grant : 항생제내성균주은행

References

  1. Babady NE, Gilhuley K, Cianciminio-Bordelon D, Tang YW. Performance characteristics of the Cepheid Xpert vanA assay for rapid identification of patients at high risk for carriage of vancomycin-resistant Enterococci. J Clin Microbiol 2012;50:3659-63. https://doi.org/10.1128/JCM.01776-12
  2. Courvalin P. Vancomycin resistance in gram-positive cocci. Clin Infect Dis 2006;42(S1):S25-34. https://doi.org/10.1086/491711
  3. Bell JM, Paton JC, Turnidge J. Emergence of vancomycin-resistant enterococci in Australia: phenotypic and genotypic characteristics of isolates. J Clin Microbiol 1998;36:2187-90.
  4. Mak A, Miller MA, Chong G, Monczak Y. Comparison of PCR and culture for screening of vancomycin-resistant Enterococci: highly disparate results for vanA and vanB. J Clin Microbiol 2009;47:4136-7. https://doi.org/10.1128/JCM.01547-09
  5. Park IJ, Lee WG, Lee H, Yong D, Lee K, Kim EC, et al. Mechanism of vanB phenotype in vancomycin-resistant Enterococci carrying vanA gene. Korean J Lab Med 2006;26:412-7. https://doi.org/10.3343/kjlm.2006.26.6.412
  6. DiazGranados CA, Zimmer SM, Klein M, Jernigan JA. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis. Clin Infect Dis 2005;41:327-33. https://doi.org/10.1086/430909
  7. Salgado CD and Farr BM. Outcomes associated with vancomycin-resistant enterococci: a meta-analysis. Infect Control Hosp Epidemiol 2003;24:690-8. https://doi.org/10.1086/502271
  8. Bonten MJ, Slaughter S, Ambergen AW, Hayden MK, van Voorhis J, Nathan C, et al. The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable. Arch Intern Med 1998;158:1127-32. https://doi.org/10.1001/archinte.158.10.1127
  9. Perl TM. The threat of vancomycin resistance. Am J Med 1999;106:26S-37S; discussion 48S-52S. https://doi.org/10.1016/S0002-9343(98)00354-4
  10. Roger M, Faucher MC, Forest P, St-Antoine P, Coutlee F. Evaluation of a vanA-specific PCR assay for detection of vancomycin-resistant Enterococcus faecium during a hospital outbreak. J Clin Microbiol 1999;37:3348-9.
  11. Seo JY, Kim PW, Lee JH, Song JH, Peck KR, Chung DR, et al. Evaluation of PCR-based screening for vancomycin-resistant enterococci compared with a chromogenic agar-based culture method. J Med Microbiol 2011;60:945-9. https://doi.org/10.1099/jmm.0.029777-0
  12. Bae MH, Kim J, Sung H, Jeong YS, Kim MN. Evaluation of iNtRON VRE vanA/vanB real-time PCR for follow-up surveillance of VRE-infected or colonized patients. Diagn Microbiol Infect Dis 2013;77:292-5. https://doi.org/10.1016/j.diagmicrobio.2013.08.006
  13. Steingart KR, Sohn H, Schiller I, Kloda LA, Boehme CC, Pai M, et al. Xpert$^{(R)}$ MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev 2013;1:CD009593.
  14. Cekin Y, Erman Daloglu A, Ogunc D, Ozhak Baysan B, Daglar D, Inan D, et al. Evaluation of vancomycin resistance 3 multiplexed PCR assay for detection of vancomycin-resistant enterococci from rectal swabs. Ann Lab Med 2013;33:326-30. https://doi.org/10.3343/alm.2013.33.5.326
  15. Kim TS, Kwon HL, Song SH, Song KH, Kim HB, Park KU, et al. Real-time PCR surveillance of vanA for vancomycin-resistant Enterococcus faecium. Mol Med Rep 2012;6:488-92. https://doi.org/10.3892/mmr.2012.952
  16. Werner G, Serr A, Schutt S, Schneider C, Klare I, Witte W, et al. Comparison of direct cultivation on a selective solid medium, polymerase chain reaction from an enrichment broth, and the BD $GeneOhm^{TM}$ VanR Assay for identification of vancomycin-resistant enterococci in screening specimens. Diagn Microbiol Infect Dis 2011;70:512-21. https://doi.org/10.1016/j.diagmicrobio.2011.04.004
  17. Stamper PD, Cai M, Lema C, Eskey K, Carroll KC. Comparison of the BD GeneOhm VanR assay to culture for identification of vancomycin-resistant enterococci in rectal and stool specimens. J Clin Microbiol 2007;45: 3360-5. https://doi.org/10.1128/JCM.01458-07
  18. Lleo MM, Bonato B, Tafi MC, Signoretto C, Boaretti M, Canepari P. Resuscitation rate in different enterococcal species in the viable but non-culturable state. J Appl Microbiol 2001;91:1095-102. https://doi.org/10.1046/j.1365-2672.2001.01476.x
  19. Lleo MM, Bonato B, Signoretto C, Canepari P. Vancomycin resistance is maintained in enterococci in the viable but nonculturable state and after division is resumed. Antimicrob Agents Chemother 2003;47:1154-6. https://doi.org/10.1128/AAC.47.3.1154-1156.2003
  20. D'Agata EM, Gautam S, Green WK, Tang YW. High rate of false-negative results of the rectal swab culture method in detection of gastrointestinal colonization with vancomycin-resistant enterococci. Clin Infect Dis 2002;34:167-72. https://doi.org/10.1086/338234
  21. Patel R. Enterococcal-type glycopeptide resistance genes in non-enterococcal organisms. FEMS Microbiol Lett 2000;185:1-7. https://doi.org/10.1111/j.1574-6968.2000.tb09032.x
  22. Fontana R, Ligozzi M, Pedrotti C, Padovani EM, Cornaglia G. Vancomycin-resistant Bacillus circulans carrying the vanA gene responsible for vancomycin resistance in enterococci. Eur J Clin Microbiol Infect Dis 1997;16:473-4. https://doi.org/10.1007/BF02471915
  23. Sievert DM, Rudrik JT, Patel JB, McDonald LC, Wilkins MJ, Hageman JC. Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006. Clin Infect Dis 2008;46:668-74. https://doi.org/10.1086/527392
  24. Power EG, Abdulla YH, Talsania HG, Spice W, Aathithan S, French GL. vanA genes in vancomycin-resistant clinical isolates of Oerskovia turbata and Arcanobacterium (Corynebacterium) haemolyticum. J Antimicrob Chemother 1995;36:595-606. https://doi.org/10.1093/jac/36.4.595
  25. Ligozzi M, Lo Cascio G, Fontana R. vanA gene cluster in a vancomycin-resistant clinical isolate of Bacillus circulans. Antimicrob Agents Chemother 1998;42:2055-9.
  26. Lee WG, Jernigan JA, Rasheed JK, Anderson GJ, Tenover FC. Possible horizontal transfer of the vanB2 gene among genetically diverse strains of vancomycin-resistant Enterococcus faecium in a Korean hospital. J Clin Microbiol 2001;39:1165-8. https://doi.org/10.1128/JCM.39.3.1165-1168.2001
  27. Ko KS, Baek JY, Lee JY, Oh WS, Peck KR, Lee N, et al. Molecular characterization of vancomycin-resistant Enterococcus faecium isolates from Korea. J Clin Microbiol 2005;43:2303-6. https://doi.org/10.1128/JCM.43.5.2303-2306.2005
  28. Won D, Hong KH, Yun K, Sung H, Kim MN. Occurrence of a PCR-positive but culture-negative case forvanB vancomycin-resistant Enterococci in stool surveillance. Lab Med Online 2013;3:264-8. https://doi.org/10.3343/lmo.2013.3.4.264
  29. Seol CA, Park JS, Sung H, Kim MN. Co-colonization of vanA and vanB Enterococcus faecium of clonal complex 17 in a patient with bacteremia due to vanA E. faecium. Diagn Microbiol Infect Dis 2014;79:141-3. https://doi.org/10.1016/j.diagmicrobio.2014.02.018

Cited by

  1. Bacterial genome sequencing in clinical microbiology: a pathogen-oriented review vol.36, pp.11, 2017, https://doi.org/10.1007/s10096-017-3024-6
  2. A Decade of Development of Chromogenic Culture Media for Clinical Microbiology in an Era of Molecular Diagnostics vol.30, pp.2, 2015, https://doi.org/10.1128/cmr.00097-16
  3. Evaluation of GeneXpert vanA/vanB in the early diagnosis of vancomycin-resistant enterococci infection vol.15, pp.11, 2015, https://doi.org/10.1371/journal.pntd.0009869